2018 甲氨蝶呤治疗幼年特发性关节炎建议

2018-07-11 意大利风湿病学研究组 Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46.

少年特发性关节炎常规治疗药物由非生物、疾病修饰的抗风湿药物组成,最常应用的药物为甲氨蝶呤。本文主要针对应用甲氨蝶呤治疗幼年特发性关节炎提出指导建议,内容涉及甲氨蝶呤的安全性和有效性,治疗剂量,减量和停药,叶酸的补充等。

中文标题:

2018 甲氨蝶呤治疗幼年特发性关节炎建议

英文标题:

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

发布日期:

2018-07-11

简要介绍:

少年特发性关节炎常规治疗药物由非生物、疾病修饰的抗风湿药物组成,最常应用的药物为甲氨蝶呤。本文主要针对应用甲氨蝶呤治疗幼年特发性关节炎提出指导建议,内容涉及甲氨蝶呤的安全性和有效性,治疗剂量,减量和停药,叶酸的补充等。 

拓展指南:甲氨蝶呤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 甲氨蝶呤治疗幼年特发性关节炎建议)] GetToolGuiderByIdResponse(projectId=1, id=174e91c00161e187, title=2018 甲氨蝶呤治疗幼年特发性关节炎建议, enTitle=Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting., guiderFrom=Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46., authorId=null, author=, summary=少年特发性关节炎常规治疗药物由非生物、疾病修饰的抗风湿药物组成,最常应用的药物为甲氨蝶呤。本文主要针对应用甲氨蝶呤治疗幼年特发性关节炎提出指导建议,内容涉及甲氨蝶呤的安全性和有效性,治疗剂量,减量和停药,叶酸的补充等。 , cover=, journalId=null, articlesId=null, associationId=1686, associationName=意大利风湿病学研究组, associationIntro=, copyright=0, guiderPublishedTime=Wed Jul 11 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>少年特发性关节炎常规治疗药物由非生物、疾病修饰的抗风湿药物组成,最常应用的药物为甲氨蝶呤。本文主要针对应用甲氨蝶呤治疗幼年特发性关节炎提出指导建议,内容涉及甲氨蝶呤的安全性和有效性,治疗剂量,减量和停药,叶酸的补充等。 </div> <div><br> </div> 拓展指南:<strong>与<font color="red">甲氨蝶呤</font>相关指南:</strong><br><ul><li><a title="2017 共识指南:应用羧肽酶治疗高剂量甲氨蝶呤引起急性肾损伤以及甲氨蝶呤清除延迟患者" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=31a961c00151a3d5">2017 共识指南:应用羧肽酶治疗高剂量甲氨蝶呤引起急性肾损伤以及甲氨蝶呤清除延迟患者</a></li> <li><a title="2016 BAD指南:皮肤疾病甲氨蝶呤处方用药的安全性和有效性" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=eb60c1c001a436eb">2016 BAD指南:皮肤疾病甲氨蝶呤处方用药的安全性和有效性</a></li> <li><a title="2013 AGA 炎性克罗恩病使用巯嘌呤类药物、甲氨蝶呤以及抗肿瘤坏死因子生物制剂诱导和维持缓解的临床指南" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=6335a1c00103167a">2013 AGA 炎性克罗恩病使用巯嘌呤类药物、甲氨蝶呤以及抗肿瘤坏死因子生物制剂诱导和维持缓解的临床指南</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E6%B0%A8%E8%9D%B6%E5%91%A4">有关甲氨蝶呤更多指南</a></ul>, tagList=[TagDto(tagId=1024, tagName=甲氨蝶呤), TagDto(tagId=22310, tagName=幼年特发性关节炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7682, appHits=161, showAppHits=0, pcHits=5340, showPcHits=2985, likes=110, shares=3, comments=11, approvalStatus=1, publishedTime=Wed Jul 18 22:35:16 CST 2018, publishedTimeString=2018-07-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jul 18 22:35:16 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:57:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 甲氨蝶呤治疗幼年特发性关节炎建议)])
2018 甲氨蝶呤治疗幼年特发性关节炎建议
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2089002, encodeId=316a20890021a, content=中国大剂量<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a><a href='/topic/show?id=35d6104e6978' target=_blank style='color:#2F92EE;'>#循证用药#</a>指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>等<a href='/topic/show?id=9f9b104e705a' target=_blank style='color:#2F92EE;'>#免疫相关性皮肤病#</a>、<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>、<a href='/topic/show?id=a11d4908306' target=_blank style='color:#2F92EE;'>#幼年特发性关节炎#</a>、<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>,算是经典的老药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69813, encryptionId=674769813be, topicName=甲氨蝶呤), TopicDto(id=104769, encryptionId=35d6104e6978, topicName=循证用药), TopicDto(id=96630, encryptionId=d4d196630b4, topicName=银屑病), TopicDto(id=104770, encryptionId=9f9b104e705a, topicName=免疫相关性皮肤病), TopicDto(id=76175, encryptionId=7face61750b, topicName=类风湿性关节炎), TopicDto(id=49083, encryptionId=a11d4908306, topicName=幼年特发性关节炎), TopicDto(id=52932, encryptionId=3ce252932f0, topicName=恶性肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Mon Sep 19 10:41:47 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332827, encodeId=fa9133282e9c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jul 20 06:16:17 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332661, encodeId=6457332661f4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Jul 19 08:24:52 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332641, encodeId=3b86332641ff, content=甲氨蝶呤治疗幼年特发性关节炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Jul 19 07:14:16 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332625, encodeId=c86733262574, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jul 19 06:45:16 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2022-09-19 小小医者

    中国大剂量#甲氨蝶呤##循证用药#指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括#银屑病##免疫相关性皮肤病##类风湿性关节炎##幼年特发性关节炎##恶性肿瘤#,算是经典的老药

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2089002, encodeId=316a20890021a, content=中国大剂量<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a><a href='/topic/show?id=35d6104e6978' target=_blank style='color:#2F92EE;'>#循证用药#</a>指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>等<a href='/topic/show?id=9f9b104e705a' target=_blank style='color:#2F92EE;'>#免疫相关性皮肤病#</a>、<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>、<a href='/topic/show?id=a11d4908306' target=_blank style='color:#2F92EE;'>#幼年特发性关节炎#</a>、<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>,算是经典的老药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69813, encryptionId=674769813be, topicName=甲氨蝶呤), TopicDto(id=104769, encryptionId=35d6104e6978, topicName=循证用药), TopicDto(id=96630, encryptionId=d4d196630b4, topicName=银屑病), TopicDto(id=104770, encryptionId=9f9b104e705a, topicName=免疫相关性皮肤病), TopicDto(id=76175, encryptionId=7face61750b, topicName=类风湿性关节炎), TopicDto(id=49083, encryptionId=a11d4908306, topicName=幼年特发性关节炎), TopicDto(id=52932, encryptionId=3ce252932f0, topicName=恶性肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Mon Sep 19 10:41:47 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332827, encodeId=fa9133282e9c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jul 20 06:16:17 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332661, encodeId=6457332661f4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Jul 19 08:24:52 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332641, encodeId=3b86332641ff, content=甲氨蝶呤治疗幼年特发性关节炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Jul 19 07:14:16 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332625, encodeId=c86733262574, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jul 19 06:45:16 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2089002, encodeId=316a20890021a, content=中国大剂量<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a><a href='/topic/show?id=35d6104e6978' target=_blank style='color:#2F92EE;'>#循证用药#</a>指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>等<a href='/topic/show?id=9f9b104e705a' target=_blank style='color:#2F92EE;'>#免疫相关性皮肤病#</a>、<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>、<a href='/topic/show?id=a11d4908306' target=_blank style='color:#2F92EE;'>#幼年特发性关节炎#</a>、<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>,算是经典的老药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69813, encryptionId=674769813be, topicName=甲氨蝶呤), TopicDto(id=104769, encryptionId=35d6104e6978, topicName=循证用药), TopicDto(id=96630, encryptionId=d4d196630b4, topicName=银屑病), TopicDto(id=104770, encryptionId=9f9b104e705a, topicName=免疫相关性皮肤病), TopicDto(id=76175, encryptionId=7face61750b, topicName=类风湿性关节炎), TopicDto(id=49083, encryptionId=a11d4908306, topicName=幼年特发性关节炎), TopicDto(id=52932, encryptionId=3ce252932f0, topicName=恶性肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Mon Sep 19 10:41:47 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332827, encodeId=fa9133282e9c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jul 20 06:16:17 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332661, encodeId=6457332661f4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Jul 19 08:24:52 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332641, encodeId=3b86332641ff, content=甲氨蝶呤治疗幼年特发性关节炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Jul 19 07:14:16 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332625, encodeId=c86733262574, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jul 19 06:45:16 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 131****1460

    学习了受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2089002, encodeId=316a20890021a, content=中国大剂量<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a><a href='/topic/show?id=35d6104e6978' target=_blank style='color:#2F92EE;'>#循证用药#</a>指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>等<a href='/topic/show?id=9f9b104e705a' target=_blank style='color:#2F92EE;'>#免疫相关性皮肤病#</a>、<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>、<a href='/topic/show?id=a11d4908306' target=_blank style='color:#2F92EE;'>#幼年特发性关节炎#</a>、<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>,算是经典的老药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69813, encryptionId=674769813be, topicName=甲氨蝶呤), TopicDto(id=104769, encryptionId=35d6104e6978, topicName=循证用药), TopicDto(id=96630, encryptionId=d4d196630b4, topicName=银屑病), TopicDto(id=104770, encryptionId=9f9b104e705a, topicName=免疫相关性皮肤病), TopicDto(id=76175, encryptionId=7face61750b, topicName=类风湿性关节炎), TopicDto(id=49083, encryptionId=a11d4908306, topicName=幼年特发性关节炎), TopicDto(id=52932, encryptionId=3ce252932f0, topicName=恶性肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Mon Sep 19 10:41:47 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332827, encodeId=fa9133282e9c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jul 20 06:16:17 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332661, encodeId=6457332661f4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Jul 19 08:24:52 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332641, encodeId=3b86332641ff, content=甲氨蝶呤治疗幼年特发性关节炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Jul 19 07:14:16 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332625, encodeId=c86733262574, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jul 19 06:45:16 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 liumin1987

    甲氨蝶呤治疗幼年特发性关节炎

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2089002, encodeId=316a20890021a, content=中国大剂量<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a><a href='/topic/show?id=35d6104e6978' target=_blank style='color:#2F92EE;'>#循证用药#</a>指南,虽然甲氨蝶呤是老药,但是在众多疾病中均广泛应用,包括<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>等<a href='/topic/show?id=9f9b104e705a' target=_blank style='color:#2F92EE;'>#免疫相关性皮肤病#</a>、<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>、<a href='/topic/show?id=a11d4908306' target=_blank style='color:#2F92EE;'>#幼年特发性关节炎#</a>、<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>,算是经典的老药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69813, encryptionId=674769813be, topicName=甲氨蝶呤), TopicDto(id=104769, encryptionId=35d6104e6978, topicName=循证用药), TopicDto(id=96630, encryptionId=d4d196630b4, topicName=银屑病), TopicDto(id=104770, encryptionId=9f9b104e705a, topicName=免疫相关性皮肤病), TopicDto(id=76175, encryptionId=7face61750b, topicName=类风湿性关节炎), TopicDto(id=49083, encryptionId=a11d4908306, topicName=幼年特发性关节炎), TopicDto(id=52932, encryptionId=3ce252932f0, topicName=恶性肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Mon Sep 19 10:41:47 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332827, encodeId=fa9133282e9c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jul 20 06:16:17 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332661, encodeId=6457332661f4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Jul 19 08:24:52 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332641, encodeId=3b86332641ff, content=甲氨蝶呤治疗幼年特发性关节炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Jul 19 07:14:16 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332625, encodeId=c86733262574, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jul 19 06:45:16 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 zb1235672

    学习了

    0